Table 2.
Distribution of COVID-19 clinical symptoms in different regions during the first six months of the pandemic.
| Country (cases) | Clinical features of COVID-19 |
||
|---|---|---|---|
| Asymptomatic | Mild symptoms | Severe symptoms | |
| Bangladesh (160000) |
80% | Fever, dry cough, tiredness, aches, muscle pains, sore throat, diarrhea, conjunctivitis, headache, loss of taste or smell, rash, discoloration of fingers | Shortness of breath, chest pain |
| China (56000) |
- | Fever, dry cough, tiredness, aches, muscle pains, sputum production, sore throat, headache, chill, nausea, vomiting, nasal congestion, diarrhea | Shortness of breath, chest pain |
| India (100000) |
63% | Cough, fever, sore throat, headache, chill, nausea, vomiting, nasal congestion, diarrhea | Shortness of breath |
| England (4000000) |
78% | Cough, fever, loss of smell (anosmia), tiredness, headache, chill, nausea, | Shortness of breath, chest pain |
| Italy (33532) |
40% | Fever, cough, chill, nausea, diarrhea | Shortness of breath |
| Spain (61075) |
66% | Fever, chills, tiredness, sore throat, cough, headache or nausea, vomiting, diarrhea, loss of smell | Shortness of breath |
| Brazil (170000) |
9% | Changes in taste and smell, headache, fever, cough, palpitation, vomiting, nausea, diarrhea | Shortness of breath |
| South Africa (150000) |
50–60% | Cough, fever, loss of smell, headache, chill, nausea, vomiting, nasal congestion, diarrhea | Shortness of breath |
| USA (373,883) |
40% | Fever, dry cough, sore throat, myalgia, loss of taste or smell, headache, chill, nausea, vomiting, nasal congestion, diarrhea, runny nose, abdominal pain | Shortness of breath |
| Australia (8000) |
15% | Fever, dry cough, sore throat, myalgia, loss of taste or smell, headache, | Shortness of breath |
The bold in the table indicated the most prevalent symptoms.